M.R. v. Eli Lilly: Mounjaro Pancreatitis Settlement
A 45-year-old patient who developed acute pancreatitis requiring hospitalization after 8 months of Mounjaro use received an $850,000 settlement.
Case Background
M.R., a 45-year-old man from Indianapolis, Indiana, was prescribed Mounjaro in March 2023 for management of his type 2 diabetes. He had a history of asymptomatic gallstones but had never experienced pancreatitis or significant gastrointestinal issues.
After approximately 6 months of treatment, M.R. began experiencing severe abdominal pain, nausea, and vomiting. He presented to the emergency department in November 2023 with acute pancreatitis.
Medical Diagnosis
M.R. was diagnosed with acute pancreatitis based on:
- Elevated lipase and amylase levels (more than 3 times the upper limit of normal)
- CT scan showing pancreatic inflammation without necrosis
- Clinical symptoms including severe epigastric pain, nausea, and vomiting
He was hospitalized for 8 days and required IV fluids, pain management, and nutritional support. After discharge, he continued to experience pancreatic insufficiency requiring enzyme replacement therapy.
Legal Proceedings
M.R. filed a lawsuit against Eli Lilly in November 2023, alleging that the company failed to adequately warn about the risk of pancreatitis associated with Mounjaro.
Key Evidence
- Medical records documenting the onset of pancreatitis during Mounjaro treatment
- Expert testimony from a gastroenterologist and endocrinologist
- FDA adverse event reports showing pancreatitis cases associated with tirzepatide
- The FDA's boxed warning regarding thyroid tumors, which plaintiffs argued showed the company was aware of serious risks
Legal Hurdles
The defense argued that M.R.'s pre-existing gallstones were the likely cause of his pancreatitis, as gallstone pancreatitis is the most common form of the condition. However, expert testimony established that:
- M.R.'s gallstones had been asymptomatic for years prior to starting Mounjaro
- The pancreatitis occurred without any gallstone-related symptoms (biliary colic) preceding it
- Mounjaro's dual GIP/GLP-1 mechanism has a known association with pancreatitis
- The timing of the pancreatitis onset correlated with the duration of Mounjaro use
Settlement
After 4 months of litigation, Eli Lilly agreed to an $850,000 settlement. The settlement covered:
- Hospitalization costs: $210,000
- Ongoing pancreatic enzyme replacement therapy: $120,000
- Lost income: $150,000
- Pain and suffering: $370,000
M.R. continues to require pancreatic enzyme replacement therapy and has been switched to a different diabetes medication.
Legal Hurdles
The defense argued that the patient's pre-existing gallstones could have caused the pancreatitis. Expert medical testimony established that Mounjaro's dual GIP/GLP-1 mechanism was the primary cause, as the pancreatitis occurred while gallstones were asymptomatic and the patient had no prior episodes of pancreatitis.
Outcome
Settled for $850,000. The settlement covered hospitalization costs ($210,000), ongoing pancreatic enzyme replacement therapy ($120,000), lost income ($150,000), and pain and suffering ($370,000).
Frequently Asked Questions
Can gallstones affect my Mounjaro lawsuit?
Having gallstones does not automatically prevent you from filing a Mounjaro lawsuit. If your pancreatitis was caused or worsened by Mounjaro, you may still have a valid claim. Expert medical testimony can help establish the primary cause of your condition.
What if I was only on Mounjaro for a short time?
The duration of use does not necessarily determine eligibility for a lawsuit. Even short-term use of Mounjaro can cause serious injuries like pancreatitis. What matters is whether the medication caused your injury.
How is pancreatitis from Mounjaro diagnosed?
Pancreatitis is typically diagnosed through blood tests showing elevated pancreatic enzymes (lipase and amylase), imaging studies (CT scan or MRI), and clinical symptoms including severe abdominal pain, nausea, and vomiting.
Can I file a claim if I was taking Mounjaro off-label?
Yes. Even if you were prescribed Mounjaro for a condition other than type 2 diabetes (such as weight loss), you may still have a valid claim if you were injured by the medication.
What if I've recovered from pancreatitis?
Even if you have recovered from acute pancreatitis, you may still have a valid claim. Some patients experience long-term pancreatic damage or recurrent episodes. Compensation can cover past medical expenses, lost wages, and pain and suffering even if you have recovered.